Oct 6, 2020 · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 8 Department of Clinical Haematology, Barwon Health, ...

Sep 18, 2019 · This study examined the suitability of health insurance claims data for assessing and explaining geographic variations in mammography screening ...

Background: Atorvastatin is very effective in reducing plasma low-density lipoprotein cholesterol (LDL-C) levels. However, there is no long-term survival study ...

This study demonstrated that patients with early-stage Hodgkin's disease experience a short-term decrease in QOL and an increase in symptoms and fatigue ...

Arterial ischemia and hemorrhage are associated with bevacizumab, an inhibitor of vascular endothelial growth factor that is widely used to treat many types ...

This tool uses predefined filters to help you quickly refine PubMed searches on clinical or disease-specific topics. To use this tool, enter your search terms ...

The study regimen consisting of 2 cycles of neoadjuvant therapy was completed without a clinically significant QOL deterioration. A transient increase in ...

RhoC had high specificity (88%) in detecting invasive carcinomas with metastatic potential. Of the invasive carcinomas smaller than 1 cm, RhoC was highly ...